Amorphous AI raises $2.2M to turn messy clinical notes into searchable data
What's the deal? Amorphous AIDealroom has a profile for this one. Try Dealroom →, an Oxford-based health tech startup, has closed a $2.2 million pre-seed round co-led by Specialist VCDealroom has a profile for this one. Try Dealroom → and Calm/Storm VenturesDealroom has a profile for this one. Try Dealroom →. The financing will fund the company's push to convert unstructured clinical documentation into structured, searchable hospital records.
Who else is in? PurposeTechDealroom has a profile for this one. Try Dealroom →, Z FellowsDealroom has a profile for this one. Try Dealroom →, BADideas.fundDealroom has a profile for this one. Try Dealroom →, and Outlast FundDealroom has a profile for this one. Try Dealroom → all participated, alongside unnamed angel investors across the US and Europe. Calm/Storm, a Europe-focused healthtech fund, recently closed a new vehicle; Outlast is a Riga-based outfit.
What's the endgame? Incorporated in the UK in January, Amorphous uses standard medical terminology systems to make sense of sprawling, handwritten and often cryptic patient notes. It has built two products: Data Engine, which translates free text into structured records using standards including SNOMED CT and ICD-10, and Striata, an AI query layer for hospital staff.
The company claims Data Engine achieves 97.8% entity recall, though that figure comes from an internal whitepaper without a publication date.
Why now? SNOMED InternationalDealroom has a profile for this one. Try Dealroom →, the nonprofit overseeing global clinical terminology standards, featured Striata in August, saying the tool "ingests raw text, de-identifies it, and maps every concept to SNOMED CT in real time." Amorphous has begun early pilots, including one with Latvia's National Health Service, but has yet to publish outcome data.
A lean team. Chief executive officer Nikita Trojanskis co-founded the startup with chief technology officer Dylan Sandfelder. Headcount is estimated in the single digits — scrappy territory for a company tackling the tangled problem of hospital data infrastructure.
What could go wrong? Amorphous is entering a crowded market. Health UniverseDealroom has a profile for this one. Try Dealroom → secured $6 million from Kleiner Perkins in March, Dandelion Health raised $14 million in May, and MDClone launched a generative AI data assistant around the same time. At $2.2 million, this pre-seed sits in roughly the 34th percentile by round size — modest capital against well-funded rivals.
The company declined to share its valuation. A LinkedIn post in April mentioned a $1.9 million close, suggesting the round expanded by $300,000 before the formal announcement.
The signal: Regulation is opening the door. US rules effective January 1, 2023 require certified electronic health record systems to offer standardized FHIR APIs, forcing hospitals to expose their data to third-party developers. That shift has lowered historical barriers to interoperability — and given challengers like Amorphous a lane to compete.
Image credit: Generated with Gemini
Read more: Founderland
